Abstract
INTRODUCTION: To explore the role of PINK1/Parkin-mediated mitochondrial autophagy in H(2)O(2)-induced abnormal proliferation of rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS). METHODS: Firstly, we isolated fibroblast like synoviocytes (RA-FLS) from RA patients. H(2)O(2)-induced oxidative stress, and NAC (a ROS inhibitor) or FCCP (a mitochondrial autophagy activator) treatment inhibited ROS level or activate mitochondrial autophagy in RA-FLS. MitoSOX Red, JC-1 kit, DCFH-DA kit and CCK8 kit were used to evaluate mitochondrial redox status, mitochondrial membrane potential, intracellular ROS level and cell activity, respectively. Western blot was used to detect the protein expression. The rat model of Freund's complete adjuvant arthritis (AA) was established and treated with NAC and FCCP, respectively. The pathological changes of synovium and the percentage of apoptotic cells in synovium were detected by H&E and TUNEL staining, respectively. RESULTS: We have successfully isolated synovial cells from RA patients. Using 5μM H(2)O(2) to stimulate RA-FLS could induce mitochondrial abnormalities of RA-FLS and inhibit RA-FLS autophagy. FCCP could reverse the effect of H(2)O(2) on RA-FLS cell proliferation and apoptosis. NAC could reverse the effect of H(2)O(2) on PINK1/Parkin. Overexpression of PINK1 or Parkin reversed the effect of H(2)O(2) on RA-FLS mitochondrial autophagy, proliferation and apoptosis. The in vivo experiment results showed that both NAC and FCCP could prevent the pathogenesis of RA, reduce RA-FLS cell viability and increase RA-FLS cell apoptosis. CONCLUSION: The PINK1/Parkin-mediated mitochondrial autophagy participates in H(2)O(2)-induced abnormal proliferation of RA-FLS, and targeting of PINK1/Parkin-mediated mitochondrial autophagy may be the key mechanism in the treatment of RA.